Task: Answer the multiple-choice question.
Question: Which drug exhibits a -16.360% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a) CC1CCCN(C(=O)Nc2ccc(Br)cc2Cl)C1
b) CCOC(=O)c1ccc(NS(=O)(=O)c2c(C)n(C)c(=O)n(C)c2=O)cc1
Answer: a. CC1CCCN(C(=O)Nc2ccc(Br)cc2Cl)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCCN(C(=O)Nc2ccc(Br)cc2Cl)C1
CC1CCCN(C(=O)Nc2ccc(Br)cc2Cl)C1
N-(4-bromo-2-chlorophenyl)-3-methylpiperidine-1-carboxamide